Gene Therapy

TLC BioSciences is at the forefront of gene therapy, with our cutting-edge LNP platform delivering genetic treatments with precision. Our therapies, like TLC501 and TLC502, target genetic disorders at their root, offering lasting solutions. We're committed to innovation, with a strong patent portfolio and investor support, as we bring transformative therapies from lab to life

  • Enhanced protection and delivery
  • Size-agnostic and scalable
  • Controlled release
  • Safety advantages
  • Stability and binding